STOCK TITAN

Vanguard disaggregates holdings after realignment; Cerus Corp (NASDAQ: CERS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Cerus Corp Schedule 13G/A amendment: The Vanguard Group reports zero beneficial ownership of Cerus Corp common stock following an internal realignment. The filing states that, after the January 12, 2026 realignment, certain Vanguard subsidiaries will report holdings separately and Vanguard no longer is deemed to beneficially own shares held by those subsidiaries.

The filing is signed by Vanguard's Head of Global Fund Administration on March 26, 2026, and lists 0 shares and 0% ownership with no voting or dispositive power.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings; reported 0 shares of Cerus Corp.

The filing documents an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries report beneficial ownership separately. The Schedule 13G/A shows 0 shares and 0% beneficial ownership, with no sole or shared voting or dispositive power listed.

Implications depend on subsidiary filings: subsequent disaggregated 13G/13G/A entries from Vanguard affiliates may show holdings. Cash‑flow treatment and any subsidiary positions are not described in this excerpt; subsequent filings will provide holder‑level detail.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does Vanguard's Schedule 13G/A for CERS report?

It reports 0 shares and 0% beneficial ownership of Cerus Corp common stock. The filing states Vanguard no longer deems itself beneficial owner of shares held by certain subsidiaries after an internal realignment on January 12, 2026.

Why does Vanguard say it will report holdings separately after January 12, 2026?

Vanguard underwent an internal realignment and, per SEC Release No. 34-39538, certain subsidiaries will report beneficial ownership on a disaggregated basis. Vanguard states those subsidiaries pursue the same investment strategies as before the realignment.

Does the filing show any Vanguard voting or dispositive power in CERS?

No. The Schedule 13G/A lists 0 for sole and shared voting power and for sole and shared dispositive power, indicating Vanguard reports no control over Cerus Corp shares in this filing.

Who signed the Schedule 13G/A amendment for Vanguard?

The filing is signed by Ashley Grim, Head of Global Fund Administration, on March 26, 2026. The signature accompanies the disclosure of 0 shares and the January 12, 2026 realignment explanation.
Cerus

NASDAQ:CERS

View CERS Stock Overview

CERS Rankings

CERS Latest News

CERS Latest SEC Filings

CERS Stock Data

342.07M
184.03M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CONCORD